BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8166046)

  • 21. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
    Fischl MA
    AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.
    Abrams DI; Goldman AI; Launer C; Korvick JA; Neaton JD; Crane LR; Grodesky M; Wakefield S; Muth K; Kornegay S
    N Engl J Med; 1994 Mar; 330(10):657-62. PubMed ID: 7906384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
    Fernández-Cruz E
    Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
    [No Abstract]   [Full Text] [Related]  

  • 25. Trial of three drugs for HIV-infected patients.
    Am Fam Physician; 1992 Apr; 45(4):1923. PubMed ID: 1313636
    [No Abstract]   [Full Text] [Related]  

  • 26. Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introduction.
    Broder S
    Am J Med; 1990 May; 88(5B):1S. PubMed ID: 2159701
    [No Abstract]   [Full Text] [Related]  

  • 27. Human immunodeficiency virus infection in children.
    Hoernle EH; Reid TE
    Am J Health Syst Pharm; 1995 May; 52(9):961-79. PubMed ID: 7641035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
    AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 30. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-HIV-therapy. Monotherapy with drugs delaying the course of the disease has limited effect].
    Julander I; Britton S
    Lakartidningen; 1994 Jul; 91(30-31):2759, 2762-3. PubMed ID: 7520104
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy for human immunodeficiency virus infection.
    Hirsch MS; D'Aquila RT
    N Engl J Med; 1993 Jun; 328(23):1686-95. PubMed ID: 8387640
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing an anti-HIV trio.
    Lancet; 1992 Mar; 339(8794):672. PubMed ID: 1347353
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment by antiviral drugs of HIV-infected patients].
    Mayaud C
    Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antiretroviral treatment against HIV].
    González-Lahoz J; Soriano V
    Med Clin (Barc); 1995 Sep; 105(10):377-8. PubMed ID: 7475441
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-retroviral treatment. Approach to previously treated patients].
    Antela A; Podzamczer D; Ruiz I; Parras F
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():24-30. PubMed ID: 9053023
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
    Crowe S; Cooper DA; Chambers DE
    Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ddI and d4T plus protease inhibitors.
    GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Back to the nukes.
    Smart T
    GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.